Health News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Extended Use Of Breast Cancer Drug Could Produce Better Results

Extended Use Of Breast Cancer Drug Could Produce Better Results
2/4/2013 1:25 PM ET

Extended use of Tamoxifen could be beneficial to breast cancer patients, says a new study from researchers at Oxford University in England. The industry leading drug is usually prescribed for a five-year period, but new data suggested a longer time frame could be better.

For the study researchers reviewed data collected as part of the Adjuvant Tamoxifen: Longer Against Shorter study beginning in 1996. The subjects were broken into five-year and ten-year groups. They found that those women who took the drug for ten years had a significantly lower risk of both recurrence and death.

"While you do get more side effects long term, the benefits significantly outweighed the side effects," said lead researcher Dr. Rosemary Leeming. "The risk of recurrence was significantly reduced. So was the risk of dying."

"Whether it's five additional years of tamoxifen or five years of another anti-estrogen drug, we may find that the long-term benefits are there," Leeming said.

The data appears this month in the Lancet and the study was partially funded by Tamoxifen maker AstraZeneca.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Health News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.